Shengfeng Hu
- Immunology top 10%
- interferon and immune responses 9
- Immune Cell Function and Interaction 8
- Immune Response and Inflammation 8
- Immune cells in cancer 7
- Infectious Diseases top 10%
-
- Ubiquitin and proteasome pathways 5
- Inflammasome and immune disorders 5
-
- Autophagy in Disease and Therapy 6
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Journals
- Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Shengfeng Hu
40 papers receiving 744 citations
Peers
Comparison fields: 5 of 89
- Immunology 321
- Cancer Research 116
- Infectious Diseases 138
- Molecular Biology 331
- Epidemiology 150
Countries citing papers authored by Shengfeng Hu
This map shows the geographic impact of Shengfeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengfeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengfeng Hu more than expected).
Fields of papers citing papers by Shengfeng Hu
This network shows the impact of papers produced by Shengfeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengfeng Hu. The network helps show where Shengfeng Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengfeng Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 28 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 10 | |
| 10 | UCHL1 Promoted Polarization of M1 Macrophages by Regulating the PI3K/AKT Signaling Pathway | 2022 | 14 |
| 11 | 2022 | 1 | |
| 12 | 2021 | 18 | |
| 13 | 2019 | 8 | |
| 14 | 2018 | 17 | |
| 15 | 2017 | 53 | |
| 16 | 2016 | 68 | |
| 17 | 2015 | 34 | |
| 18 | 2015 | 17 | |
| 19 | 2014 | 23 | |
| 20 | 2012 | 30 |
About Shengfeng Hu
Shengfeng Hu is a scholar working on Immunology, Physiology and Biological Psychiatry, having authored 41 papers that have together received 748 indexed citations. Recurring topics across this work include interferon and immune responses (9 papers), Immune Cell Function and Interaction (8 papers), Immune Response and Inflammation (8 papers), Immune cells in cancer (7 papers), Autophagy in Disease and Therapy (6 papers), Ubiquitin and proteasome pathways (5 papers), Inflammasome and immune disorders (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Immunology (321 citations), Cancer Research (116 citations) and Infectious Diseases (138 citations). Shengfeng Hu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Li Ma, Xialin Du, Qian Wen, Jiahui Yang, Wenting He, Xiao‐Ping Zhong, Chaoying Zhou, Xinying Zhou, Xiaoxia Zhan and Yuling Fu. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.